Roche says hemophilia drug Hemlibra wins EU approval

ZURICH (Reuters) - Swiss group Roche said on Tuesday the European Commission has approved its drug Hemlibra for people with hemophilia A who have developed resistance to standard treatments.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news